EU/3/14/1401

About

On 16 December 2014, orphan designation (EU/3/14/1401) was granted by the European Commission to Dr Laurent Vinay, France, for riluzole for the treatment of traumatic spinal cord injury.

Key facts

Active substance
Riluzole
Disease / condition
Treatment of traumatic spinal cord injury
Date of first decision
16/12/2014
Outcome
Positive
EU designation number
EU/3/14/1401

Review of designation

Sponsor's contact details

Dr Laurent Vinay
Institut des Neurosciences de la Timone
Campus Santé Timone
27 bd Jean Moulin
13385 Marseille cedex 05
France
Tel. +33 4 91 32 40 51
Fax +33 4 91 32 40 56
E-mail: laurent.vinay@univ-amu.fr

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating